Fund Management At Engine No. 1 LLC Abbott Laboratories Transaction History

Fund Management At Engine No. 1 LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $208,064 - $249,642	2,178 Added 9.62%	24,819 $2.4 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $150,363 - $167,536	1,492 Added 7.05%	22,641 $2.47 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $189,361 - $222,889	1,955 Added 10.19%	21,149 $2.14 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $223,961 - $262,741	2,356 Added 13.99%	19,194 $2.11 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $81,568 - $94,441	-843 Reduced 4.77%	16,838 $1.63 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $276,609 - $334,332	2,710 Added 18.1%	17,681 $1.92 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $1.71 Million - $2.08 Million	14,971 New	14,971 $1.77 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Fund Management At Engine No. 1 LLC, based on Form 13F filings with the SEC.

Stay updated on Fund Management At Engine No. 1 LLC with notifications on news.